Migraine disorder

Related records

Broader conditions (12)

• Brain disorder
• Cardiovascular disorder
• Central nervous system disorder
• Disease
• Disease by body system or component
• Headache disorder
• Human disease
• Hypnic headache
• Nervous system disorder
• Neurological pain disorder
• Neurovascular disorder
• Vascular disorder

Narrower conditions (11)

• Familial hemiplegic migraine
• Familial or sporadic hemiplegic migraine
• Hemiplegic migraine-developmental and epileptic encephalopathy spectrum
• Migraine with aura
• Migraine with brainstem aura
• Migraine without aura
• Migraine, familial hemiplegic, 1
• Migraine, familial hemiplegic, 2
• Migraine, familial hemiplegic, 3
• Migraine, familial hemiplegic, 4
• Sporadic hemiplegic migraine

Trials (1,469)

• "Completeness of Response" Following Treatment With Treximet™ for Migraine
• "Follow the Sutures". A New Procedure for Injection of Botulinum Toxin for Chronic Migraine
• "Longitudinal Analysis of Amylin Levels in Migraine Patients Undergoing an Anti- CGRP/CGRPr Treatment"
• "Personalized Physiotherapy for Migraine: Effects on Pain, Fatigue, and Physical Function"
• "Potential Effects of Virtual Reality Technology on the Treatment of Migraine-Type Headaches"
• (Botox) Mechanisms of Action in Altering the Molecular Environment in Which Pain Fibers Exist
• (Italian Migraine Registry, I-GRAINE-NEW)
• 0.5% Bupivacaine Lower Cervical Intramuscular Injection vs IV Medications for Headache Treatment
• 12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine
• 1H Magnetic Resonance Spectroscopy in Migraine Patients
• 4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine
• A 1-year Study in Adolescents to Assess the Long-term Safety of Almotriptan Malate When Treating Their Migraine Headaches
• A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
• A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)
• A Clinical Study Examining the Safety and Effectiveness of a New Medication (Keppra®) for the Prevention of Migraine Headaches
• A Clinical Trial Evaluated the Safety and Tolerability, Pharmacokinetic and Pharmacodynamics Profile, and Immunogenicity of a Single Dose of JS010 Injection in Healthy Subjects
• A Combination of Coenzyme Q10, Feverfew and Magnesium for Migraine Prophylaxis : a Prospective Observational Study
• A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data
• A Comparison of Biodegradable and Metal Occluders in Patients With PFO and Migraine
• A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache

Approved drugs (46)

• Acetaminophen
• Almotriptan malate
• Aspirin
• Atogepant
• Botulinum toxin type A
• Butalbital
• Caffeine
• Celecoxib
• Clonidine
• Codeine phosphate
• Diclofenac
• Diclofenac potassium
• Dihydroergotamine
• Dihydroergotamine mesylate
• Divalproex sodium
• Eletriptan
• Eletriptan hydrobromide
• Eptinezumab
• Erenumab
• Ergotamine

Drugs in development (105)

• Almotriptan Phase 2
• Alniditan Phase 3
• Alprazolam Phase 1
• Amitriptyline Phase 3
• Atorvastatin Phase 2
• Avitriptan Phase 3
• BGC-20-1531 Phase 2
• BI-44370 Phase 2
• Bupivacaine Phase 3
• Bupivacaine hydrochloride Phase 2
• Buprenorphine Phase 2
• Cabergoline Phase 2
• Candesartan Phase 2
• Cannabidiol Phase 2
• Cannabinol Phase 1
• Capsaicin Early phase 1
• Carbon dioxide Phase 2
• Carisbamate Phase 2
• Cetirizine Phase 1
• Corticotropin Phase 2

Other linked drugs (16)

• Acetazolamide
• Acetazolamide sodium
• Budipine
• Cilostazol
• Daxibotulinumtoxina
• Diethylpropion
• Donitriptan
• Dotarizine
• Flunarizine hydrochloride
• Indomethacin
• Levetiracetam
• Lomerizine
• Nitroglycerin
• Olanzapine
• Soy isoflavones
• Substance P